Cargando…
Patient experience in systemic lupus erythematosus: development of novel patient-reported symptom and patient-reported impact measures
BACKGROUND: Comprehensive assessment of systemic lupus erythematosus (SLE) and its treatment requires patient-reported outcome (PRO) measures to capture impacts and fluctuating symptoms. The objective of this study was to develop PROs, in accordance with the Food and Drug Administration (FDA) PRO Gu...
Autores principales: | Mathias, S. D., Berry, P., De Vries, J., Pascoe, K., Colwell, H. H., Chang, D. J., Askanase, A. D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934913/ https://www.ncbi.nlm.nih.gov/pubmed/29757295 http://dx.doi.org/10.1186/s41687-018-0028-7 |
Ejemplares similares
-
Treatment Satisfaction in Systemic Lupus Erythematosus: Development of a Patient-Reported Outcome Measure
por: Mathias, Susan D., et al.
Publicado: (2017) -
Development of the Systemic Lupus Erythematosus Steroid Questionnaire (SSQ): a novel patient-reported outcome tool to assess the impact of oral steroid treatment
por: Mathias, Susan D., et al.
Publicado: (2017) -
Patient Evaluation of Satisfaction and Outcomes with an Autoinjector for Self-Administration of Subcutaneous Belimumab in Patients with Systemic Lupus Erythematosus
por: Dashiell-Aje, Ebony, et al.
Publicado: (2017) -
Belatacept in kidney transplant patients with systemic lupus erythematosus
por: Carrión-Barberà, Irene, et al.
Publicado: (2019) -
A Narrative Review of Repository Corticotropin Injection for the Treatment of Systemic Lupus Erythematosus
por: Askanase, Anca D., et al.
Publicado: (2022)